Foundational Science and Mechanisms of Disease

426 questions

Question 281Question →

A 68-year-old man comes to the clinic due to a 1-year history of worsening intention tremor and unsteadiness while walking. He also reports recent difficulties with short-term memory and executive function, such as managing his finances. His medical history is notable for hypertension. His family history is significant; his daughter is healthy, but his 8-year-old maternal grandson has been diagnosed with intellectual disability, a long face, prominent ears, and macroorchidism. On physical examination, the patient exhibits a bilateral intention tremor, broad-based ataxic gait, and symmetrical parkinsonian features including mild rigidity. Magnetic resonance imaging (MRI) of the brain reveals generalized cerebral atrophy and symmetrically increased T2-weighted signal in the middle cerebellar peduncles. Which of the following best describes the underlying molecular mechanism responsible for this patient's current neurologic symptoms?

Show answer & explanation

Answer: Accumulation of toxic messenger RNA

Answer

Accumulation of toxic messenger RNA
The correct answer is accumulation of toxic messenger RNA. The patient's clinical presentation (intention tremor, ataxia, parkinsonism, cognitive decline) combined with a characteristic MRI finding (increased T2 signal in the middle cerebellar peduncles) and a family history of a grandson with fragile X syndrome is highly specific for fragile X-associated tremor/ataxia syndrome (FXTAS). Fragile X syndrome is caused by a trinucleotide (CGG) repeat expansion in the FMR1 gene. The grandson has the full mutation (>200>200 repeats), which leads to hypermethylation of the FMR1 promoter and subsequent gene silencing. The patient (grandfather), however, is a carrier of the premutation (5555 to 200200 repeats). In contrast to the full mutation, the premutation results in an overexpression of FMR1 mRNA. The excess messenger RNA accumulates in the nucleus, forming toxic intranuclear inclusions in neurons and astrocytes, which eventually leads to the neurodegeneration seen in FXTAS.

Step-by-Step Solution

1
Analyze the family history to establish the genetic context.
The grandson has intellectual disability, prominent ears, and macroorchidism, classic for fragile X syndrome (FXS). The patient's daughter is an obligate carrier.
Identifying the grandson's condition is essential to recognize the X-linked inheritance pattern and the specific gene involved (FMR1).
2
Correlate the patient's symptoms and imaging with the genetic context.
The patient is an older male with intention tremor, ataxia, memory loss, and MRI evidence of middle cerebellar peduncle (MCP) hyperintensity. This establishes a diagnosis of fragile X-associated tremor/ataxia syndrome (FXTAS).
The grandfather is a premutation carrier who passed the allele to his daughter. The premutation expanded to a full mutation during the daughter's oogenesis, resulting in the grandson's FXS.
3
Determine the precise molecular mechanism for the patient's condition (premutation).
FXTAS is caused by an expansion of 5555 to 200200 CGG repeats in the FMR1 gene. Unlike the full mutation, this premutation leads to increased transcription, causing accumulation of toxic FMR1 messenger RNA.
Differentiating the molecular mechanism of the premutation (RNA toxicity) from the full mutation (gene silencing via methylation) is required to answer the question.

Key Concept

Pathophysiology and molecular mechanisms of fragile X-associated tremor/ataxia syndrome (FXTAS) compared to fragile X syndrome.
Question 282Question →

A 28-year-old man with recently diagnosed Crohn disease comes to the emergency department due to a 3-day history of high fever, chills, and severe fatigue. He also reports painful sores in his mouth. Four weeks ago, his gastroenterologist started him on azathioprine and a tapering dose of prednisone to manage a severe disease flare. His temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 110/70 mm Hg110/70\text{ mm Hg}, and pulse is 115/min115/\text{min}. Physical examination shows pale conjunctivae and multiple aphthous ulcers on the buccal mucosa. Laboratory studies show:

Laboratory TestResult
Leukocyte count1,100/mm31,100/\text{mm}^3
Absolute neutrophil count400/mm3400/\text{mm}^3
Hemoglobin7.2 g/dL7.2 \text{ g/dL}
Platelet count42,000/mm342,000/\text{mm}^3

Which of the following genetic mechanisms best explains this patient's current presentation?

Show answer & explanation

Answer: Autosomal recessive inheritance of a defective methyltransferase enzyme

Answer

Autosomal recessive inheritance of a defective methyltransferase enzyme
The correct answer describes a deficiency in thiopurine methyltransferase (TPMT). Azathioprine is a prodrug that is non-enzymatically converted to 6-mercaptopurine (6-MP). 6-MP is subsequently metabolized through distinct pathways: inactivation by TPMT, inactivation by xanthine oxidase (XO), or activation by hypoxanthine-guanine phosphoribosyltransferase (HGPRT) into 6-thioguanine nucleotides (6-TGN). 6-TGNs are purine analogs that incorporate into cellular DNA, causing cytotoxicity and immunosuppression. Patients with autosomal recessive polymorphisms in the TPMT gene have decreased or absent enzyme activity. When these patients receive normal doses of azathioprine, drug metabolism is heavily shunted toward the HGPRT pathway, resulting in a massive overproduction of cytotoxic 6-TGNs. This leads to profound, dose-dependent bone marrow suppression, presenting clinically as severe pancytopenia (fever, mucosal ulcers, anemia, bleeding). Standard practice requires testing for TPMT enzymatic activity or genotype prior to initiating thiopurine therapy.

Step-by-Step Solution

1
Analyze the clinical presentation and timeline.
The patient developed severe pancytopenia (leukopenia, anemia, thrombocytopenia) and mucosal ulcers four weeks after initiating azathioprine.
Establishing the temporal relationship between a new medication and symptom onset is critical for identifying an adverse drug reaction.
2
Identify the primary metabolic pathway of the suspected medication.
Azathioprine is a prodrug converted to 6-mercaptopurine (6-MP), which is inactivated by thiopurine methyltransferase (TPMT) or xanthine oxidase (XO).
Understanding drug metabolism pathways reveals the molecular vulnerability causing the toxicity.
3
Correlate the toxicity with the underlying genetic mechanism.
An autosomal recessive deficiency in TPMT shunts 6-MP metabolism toward the production of cytotoxic 6-thioguanine nucleotides (6-TGN), causing severe bone marrow suppression.
This confirms that a defective methyltransferase enzyme directly explains the patient's profound pancytopenia.

Key Concept

Patients with a genetic polymorphism resulting in decreased thiopurine methyltransferase (TPMT) activity are at high risk for life-threatening myelosuppression when treated with azathioprine, as the drug is shunted into cytotoxic metabolites.
Question 283Question →

Match each classic genetic principle to its defining clinical or pathophysiological description.

Click a left item, then click its matching right item

Items

A genetic disorder presents at an earlier age of onset and with more severe symptoms in successive generations of a family.
A single gene mutation causes multiple diverse phenotypic traits across different organ systems, such as simultaneous ocular, cardiovascular, and skeletal abnormalities.
The clinical expression of a disease differs significantly based on whether the responsible mutant allele was inherited from the maternal or paternal parent.
Pathogenic mutations in entirely different genes located on different chromosomes result in the exact same clinical disease presentation.

Matches

Show answer & explanation

Answer

Anticipation matches with increasing disease severity in successive generations. Pleiotropy matches with a single mutation causing diverse multi-organ traits. Genomic imprinting matches with parent-of-origin dependent disease expression. Locus heterogeneity matches with distinct gene mutations yielding identical clinical presentations.
Each definition precisely describes a foundational genetic mechanism essential for interpreting clinical genetic presentations and pedigree charts in practice. Proper alignment matches anticipation with generational severity, pleiotropy with multi-organ effects, imprinting with parent-of-origin expression, and locus heterogeneity with distinct loci causing identical phenotypes.

Step-by-Step Solution

1
Analyze the description regarding earlier onset and increased severity in successive generations.
Identified as Anticipation.
This is the textbook definition of anticipation, heavily linked to dynamic mutations like trinucleotide repeat expansions.
2
Analyze the description of diverse traits across organ systems caused by one mutation.
Identified as Pleiotropy.
Pleiotropy occurs when one underlying molecular defect has widespread, seemingly disconnected manifestations.
3
Analyze the description of parent-of-origin effects on disease expression.
Identified as Genomic imprinting.
Epigenetic methylation specific to maternal or paternal gametes drives imprinted gene expression.
4
Analyze the description of different chromosomal mutations causing the same exact disease.
Identified as Locus heterogeneity.
Different loci leading to the same phenotype defines locus heterogeneity, differentiating it from allelic heterogeneity (different mutations in the same gene).

Key Concept

Foundational genetic inheritance principles and variations
Question 284Question →

A 3-week-old male infant is evaluated in the pediatric genetics clinic for profound central hypotonia, a poor suck reflex requiring nasogastric tube feeding, and cryptorchidism. The clinical team strongly suspects Prader-Willi syndrome. Arrange the following diagnostic modalities in the correct sequential order recommended to first confirm the clinical diagnosis and subsequently determine the exact underlying molecular etiology, proceeding from the initial confirmatory test to the evaluation for the rarest genetic mechanism.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct diagnostic sequence begins with DNA methylation analysis to confirm the diagnosis, followed by chromosomal microarray to evaluate for a microdeletion, short tandem repeat analysis to evaluate for uniparental disomy, and finally sequencing of the imprinting center to identify rare defects.
The diagnostic algorithm for Prader-Willi syndrome is strictly tiered based on test sensitivity and the epidemiological frequency of the underlying molecular mechanisms. DNA methylation is the most sensitive initial test (>99%). Once confirmed, determining the exact molecular mechanism is required for genetic counseling. The mechanisms are evaluated in order of prevalence: CMA for paternal deletion (~70%), STR analysis for maternal UPD (~25%), and finally sequencing for imprinting center defects (~1-3%).

Step-by-Step Solution

1
Perform DNA methylation analysis.
Confirms the diagnosis of Prader-Willi syndrome.
It detects the lack of a functional paternal allele in over 99% of cases, making it the most sensitive initial screening test, though it does not identify the specific underlying mechanism.
2
Perform chromosomal microarray analysis (CMA).
Evaluates for a 15q11-q13 microdeletion.
Paternal microdeletion is the most common cause (70%). CMA is the most efficient next step to visualize this deletion once the disease is confirmed.
3
Perform short tandem repeat (STR) polymorphism analysis.
Evaluates for maternal uniparental disomy (UPD).
If CMA is negative, UPD is the next most likely cause (25%). STR compares the infant's alleles to both parents to confirm if both copies of chromosome 15 are maternal in origin.
4
Perform Sanger sequencing of the imprinting center.
Identifies imprinting center defects.
If STR shows normal biparental inheritance, an imprinting center defect (1-3%) is the only remaining cause. This step is critical because these defects can carry up to a 50% recurrence risk for future pregnancies.

Key Concept

Stepwise molecular diagnostic algorithm for Prader-Willi syndrome
Estimated Time:1m 30s
Question 285Question →

A 45-year-old woman undergoes a hemicolectomy for a newly diagnosed right-sided colon adenocarcinoma. Her family history is significant for a mother who had endometrial cancer at age 49. The physician suspects Lynch syndrome (hereditary nonpolyposis colorectal cancer) and initiates a stepwise molecular and genetic diagnostic workup. Assuming each diagnostic test yields findings that require proceeding to the next sequential step, arrange the following management actions in the correct chronological order.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: tumor IHC for MMR proteins, followed by tumor BRAF/methylation testing, then patient germline sequencing, and finally cascade testing of relatives.
The correct sequence reflects the established, cost-effective diagnostic algorithm for Lynch syndrome. It begins with evaluating the tumor phenotype (IHC), progresses to ruling out common somatic causes of MMR deficiency (BRAF V600E/methylation), moves to definitively diagnosing the index patient via germline sequencing, and concludes by utilizing that confirmed diagnosis to guide cascade testing for at-risk family members.

Step-by-Step Solution

1
Determine the optimal initial screening test for a patient with suspected Lynch syndrome.
Immunohistochemical (IHC) staining of the tumor tissue for mismatch repair proteins.
Universal screening of colorectal tumors using IHC (or microsatellite instability testing) is the standard first step to identify tumors with mismatch repair deficiency.
2
Determine the next step if the screening test suggests mismatch repair deficiency (e.g., loss of MLH1).
Testing the tumor for a BRAF V600E mutation and MLH1 promoter hypermethylation.
Approximately 15% of sporadic colorectal cancers show MLH1 loss due to somatic promoter hypermethylation, often alongside a BRAF V600E mutation. This step rules out sporadic disease before proceeding to expensive germline testing.
3
Identify the confirmatory test for the patient if tumor testing is consistent with an inherited etiology.
Germline sequencing of the mismatch repair genes from a peripheral blood sample.
Lynch syndrome is defined by a hereditary, germline mutation. A definitive diagnosis requires confirming this mutation in the index patient's DNA.
4
Determine the management of the patient's family members once a diagnosis is confirmed.
Offer targeted (site-specific) genetic testing to first-degree relatives.
Cascade testing of relatives is only indicated after the specific pathogenic variant responsible for the syndrome is identified in the affected index patient.

Key Concept

The diagnostic algorithm for Lynch syndrome follows a stepwise progression: phenotypic tumor screening, somatic mutation testing to rule out sporadic disease, definitive germline sequencing in the index patient, and subsequent cascade testing for relatives.
Estimated Time:1m 30s
Question 286Question →

A 54-year-old man with a 10-year history of uncontrolled gastroesophageal reflux disease undergoes an upper gastrointestinal endoscopy. A biopsy of the distal esophagus is obtained. Histologic examination of the tissue reveals the replacement of the normal stratified squamous epithelium with nonciliated, mucin-producing columnar epithelium containing goblet cells. No cytologic atypia is observed. Which of the following cellular processes best describes this histologic finding?

Show answer & explanation

Answer: Metaplasia

Answer

The correct cellular process is Metaplasia.
The histologic finding of one adult cell type (stratified squamous) being replaced by another adult cell type (columnar with goblet cells) in response to chronic acid irritation is the exact definition of metaplasia. This specific presentation describes Barrett esophagus.

Step-by-Step Solution

1
Analyze the patient's history and the anatomical site of the biopsy.
The patient has chronic gastroesophageal reflux disease (GERD), providing a source of chronic acid irritation to the distal esophagus.
Identifying the chronic stressor is necessary to determine the expected physiologic or pathologic tissue response.
2
Evaluate the specific histologic changes described in the vignette.
Normal stratified squamous epithelium has been replaced by columnar epithelium with goblet cells, without any cytologic atypia.
The presence of a new, fully differentiated adult cell type without malignant features is the defining characteristic of a specific cellular adaptation.
3
Correlate the histologic findings with fundamental definitions of cellular adaptations.
The substitution of one fully differentiated cell type by another is defined as metaplasia.
This confirms the diagnosis of Barrett esophagus, a classic example of metaplasia occurring as an adaptive response to chronic environmental stress.

Key Concept

Metaplasia is a reversible cellular adaptation where one fully differentiated adult cell type is replaced by another in response to chronic stress or irritation.
Question 287Question →

A 55-year-old man experiences a myocardial infarction, resulting in abrupt cessation of blood flow to a portion of the left ventricle. This ischemic event triggers a predictable sequence of subcellular changes leading to reversible cellular injury. Arrange the following pathophysiological events of ischemic cellular injury in the correct chronological order, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with decreased mitochondrial oxidative phosphorylation, followed by depletion of intracellular ATP stores, failure of the plasma membrane Na+/K+ ATPase pump, intracellular accumulation of sodium and water, and finally cellular and endoplasmic reticulum swelling.
Ischemic injury begins with hypoxia, which directly halts mitochondrial oxidative phosphorylation. This immediately depletes cellular ATP. Without ATP, energy-dependent processes such as the Na+/K+ ATPase pump fail. The loss of this pump causes sodium to accumulate intracellularly, which draws in water osmotically, ultimately leading to cellular and organelle swelling (hydropic change).

Step-by-Step Solution

1
Identify the primary insult of ischemia at the cellular level.
Decreased oxygen halts mitochondrial oxidative phosphorylation.
Oxygen is required as the final electron acceptor in the electron transport chain.
2
Determine the immediate biochemical consequence of halting oxidative phosphorylation.
Depletion of intracellular ATP stores.
The cell loses its primary source of energy production, and anaerobic glycolysis cannot fully compensate.
3
Identify the effect of ATP depletion on membrane transport.
Failure of the plasma membrane Na+/K+ ATPase pump.
This pump relies heavily on ATP to transport ions against their concentration gradients.
4
Assess the ionic shifts caused by pump failure.
Intracellular accumulation of sodium and water.
Sodium normally extruded by the pump remains inside the cell, pulling water with it via osmosis.
5
Determine the morphological result of this fluid influx.
Cellular and endoplasmic reticulum swelling.
The excess water physically expands the cell and its organelles, representing the classic hallmark of reversible cell injury.

Key Concept

Sequence of biochemical events in reversible ischemic cellular injury
Question 288Question →

A 32-year-old man comes to the clinic to review the results of his recent laboratory tests. He originally presented for a well-patient examination, during which firm, nodular masses were noted on his bilateral Achilles tendons. A fasting lipid panel at that time showed a low-density lipoprotein (LDL) cholesterol level of 315 mg/dL. Due to a strong family history of early-onset coronary artery disease, he was referred for targeted genetic testing. The results reveal a heterozygous gain-of-function mutation in the PCSK9 gene.

During the visit, the patient mentions that his maternal cousin, who is 35 years old, has the identical clinical phenotype consisting of tendon xanthomas and severely elevated LDL cholesterol levels. The cousin also recently underwent targeted genetic testing, but his results showed a heterozygous loss-of-function mutation in the LDLR gene.

Which of the following genetic principles best explains the presence of an identical clinical phenotype in these two relatives despite having mutations in entirely different genes?

Show answer & explanation

Answer: Locus heterogeneity

Answer

Locus heterogeneity
The correct answer is locus heterogeneity. This genetic principle describes a scenario in which a single clinical disease (phenotype) is caused by genetic mutations occurring at completely different loci (i.e., distinct, separate genes). Familial Hypercholesterolemia is a classic example of locus heterogeneity; it can result from loss-of-function mutations in the LDLR gene (which normally clears LDL from the blood), loss-of-function mutations in the APOB gene (which prevents LDL from binding the receptor), or gain-of-function mutations in the PCSK9 gene (which abnormally increases the degradation of LDL receptors). Because the patient and his cousin have the identical clinical presentation resulting from mutations in two different genes, locus heterogeneity is the correct principle.

Step-by-Step Solution

1
Analyze the clinical presentation of the patient and his cousin.
Both individuals have tendon xanthomas, severely elevated LDL cholesterol, and a family history of early-onset coronary artery disease, which defines the clinical phenotype of Familial Hypercholesterolemia.
Establishing that both patients have the exact same clinical condition is the first step in comparing their genetic backgrounds.
2
Compare the specific genetic testing results of both individuals.
The patient has a mutation in the PCSK9 gene, while the cousin has a mutation in the LDLR gene.
Identifying that the mutations reside in two entirely distinct, separate genes is necessary to define the correct genetic principle.
3
Match the clinical and genetic findings to the defining characteristics of genetic principles.
The occurrence of an identical disease phenotype caused by mutations at completely different genetic loci defines locus heterogeneity.
This confirms the underlying genetic mechanism responsible for the familial presentation.

Key Concept

Locus heterogeneity occurs when a single clinical disorder can be caused by mutations in multiple, distinct genes.
Question 289Question →

An outpatient evaluation is conducted for a 2424-year-old male who reports a two-month history of episodic, severe headaches accompanied by palpitations, profound diaphoresis, and anxiety. During the visit, his blood pressure is measured at 185/110185/110 mm Hg with a heart rate of 115115/min. Physical examination is notable for an unusually tall and slender body habitus with arachnodactyly. Examination of the oral cavity reveals multiple firm, painless, yellow-white nodules distributed across the lips and the anterior tip of the tongue. Palpation of the anterior neck identifies a firm, 22-cm nodule in the right thyroid lobe. Diagnostic laboratory studies show markedly elevated plasma free metanephrines. A review of his family history indicates that his mother passed away from a rapidly progressive neck tumor at age 3535, and his 1212-year-old brother recently underwent an elective prophylactic total thyroidectomy. Based on these clinical findings, the genetic defect responsible for this patient's condition causes which of the following molecular alterations?

Show answer & explanation

Answer: Constitutive ligand-independent activation of a transmembrane receptor tyrosine kinase

Answer

Constitutive ligand-independent activation of a transmembrane receptor tyrosine kinase
The patient's clinical presentation is highly characteristic of Multiple Endocrine Neoplasia type 2B (MEN2B). This syndrome is distinguished by the development of medullary thyroid cancer (MTC) and pheochromocytomas, accompanied by a marfanoid body habitus and mucosal neuromas (often on the lips and tongue). The family history of an early fatal 'thyroid tumor' and a brother undergoing a prophylactic total thyroidectomy strongly supports the presence of a highly penetrant, aggressive familial MTC syndrome. MEN2B is an autosomal dominant condition caused by a gain-of-function germline mutation in the RET proto-oncogene. The RET gene encodes a transmembrane receptor tyrosine kinase. Normally, this receptor requires binding by glial cell line-derived neurotrophic factor (GDNF) family ligands to dimerize and activate. However, in MEN2B (most commonly due to an M918T point mutation in the kinase domain), the receptor undergoes constitutive, ligand-independent auto-phosphorylation. This leads to persistent downstream mitogenic signaling, driving the neoplastic transformation of neural crest-derived tissues such as parafollicular C-cells and adrenal medullary chromaffin cells.

Step-by-Step Solution

1
Analyze the clinical presentation and physical exam findings.
The patient has signs of a pheochromocytoma (hypertension, headaches, elevated metanephrines), a marfanoid habitus, mucosal neuromas, and a thyroid nodule.
Identifying the complete constellation of signs is necessary to formulate an accurate syndromic diagnosis rather than anchoring on one isolated finding.
2
Synthesize the family history with the patient's presentation to establish a diagnosis.
A family history of early fatal neck tumors and prophylactic thyroidectomy indicates hereditary medullary thyroid cancer. Combined with the patient's physical findings, the diagnosis is definitively Multiple Endocrine Neoplasia type 2B (MEN2B).
Prophylactic thyroidectomy in an asymptomatic relative is a hallmark management strategy for kindreds with high-risk RET mutations, confirming the MEN2 familial pattern.
3
Determine the molecular mechanism of the genetic defect associated with MEN2B.
MEN2B is caused by an activating germline mutation in the RET proto-oncogene, which encodes a receptor tyrosine kinase that becomes constitutively active without ligand binding.
The question specifically asks for the molecular alteration caused by the genetic defect.

Key Concept

Multiple Endocrine Neoplasia type 2B (MEN2B) is caused by a gain-of-function germline mutation in the RET proto-oncogene, resulting in constitutive, ligand-independent activation of its receptor tyrosine kinase.
Question 290Question →

A 62-year-old woman is managed in the intensive care unit for gram-negative bacteremia and distributive shock. Despite appropriate antibiotic therapy and aggressive fluid resuscitation, she experiences prolonged episodes of severe hypotension over a 36-hour period. Her serum creatinine level increases rapidly from a baseline of 0.8 mg/dL to 3.2 mg/dL. Urinalysis reveals the presence of numerous muddy brown granular casts. The patient's renal dysfunction is primarily driven by ischemic damage to the proximal renal tubules. Which of the following intracellular events marks the definitive transition from reversible adaptation to irreversible cell injury in this patient's affected renal tubules?

Show answer & explanation

Answer: Profound plasma membrane damage with massive influx of calcium into the cytosol

Answer

The correct answer is profound plasma membrane damage with massive influx of calcium into the cytosol.
The patient's clinical presentation of prolonged hypotension, rising creatinine, and muddy brown casts indicates ischemic acute tubular necrosis (ATN). The presence of muddy brown casts signifies that tubular epithelial cells have undergone necrosis (cell death) and sloughed into the tubular lumen. In the sequence of ischemic cellular injury, early effects such as ATP depletion lead to reversible changes. However, the definitive transition from reversible adaptation to irreversible injury is marked by profound plasma and mitochondrial membrane damage. This structural breakdown allows a massive influx of extracellular calcium into the cytosol, which subsequently activates destructive enzymes (such as phospholipases, proteases, and endonucleases) that ultimately dismantle the cell.

Step-by-Step Solution

1
Identify the patient's clinical diagnosis from the vignette.
The patient has acute tubular necrosis (ATN) evidenced by distributive shock, rapidly rising creatinine, and muddy brown granular casts.
Muddy brown casts are pathognomonic for ATN, which involves actual cell death (necrosis) of the tubular epithelial cells due to prolonged ischemia.
2
Distinguish between the mechanisms of reversible and irreversible cellular injury.
Early ischemic changes (swelling, ribosome detachment, chromatin clumping) are reversible. The critical threshold of irreversible injury is characterized by severe damage to the plasma and mitochondrial membranes.
The question asks specifically for the event that marks the definitive transition to irreversible injury, which is the point of no return for the affected tubular cells.

Key Concept

The hallmark of irreversible ischemic cellular injury is severe structural damage to the plasma and mitochondrial membranes, which leads to a massive influx of calcium that activates destructive intracellular enzymes (phospholipases, proteases, endonucleases), culminating in necrosis.
Estimated Time:1m 0s
Question 291Question →

A 14-month-old girl is evaluated in the pediatric genetics clinic for poor weight gain, recurrent respiratory infections, and greasy, foul-smelling stools. Physical examination reveals a weight below the 3rd percentile, a prominent forehead, a triangular face, and noticeable left-sided limb hypoplasia. Sweat chloride testing is elevated. Molecular genetic testing reveals the patient is homozygous for the ΔF508\Delta F508 mutation in the CFTR gene. Carrier screening of both parents, along with microsatellite analysis confirming paternity, shows the mother is a heterozygous carrier of the ΔF508\Delta F508 mutation, whereas the father has two normal CFTR alleles. What specific underlying molecular event is most likely responsible for this child's condition?

Show answer & explanation

Answer: Maternal isodisomy of chromosome 7

Answer

Maternal isodisomy of chromosome 7
The correct answer accurately synthesizes the two distinct clinical presentations. The patient has Cystic Fibrosis (CF) and is homozygous for the CFTR mutation. Since only the mother is a carrier and paternity is confirmed, the child must have inherited two copies of the mother's mutant allele. This occurs via maternal isodisomy of chromosome 7. Crucially, maternal uniparental disomy of chromosome 7 is a known cause of Silver-Russell syndrome, an imprinting disorder characterized by severe growth retardation, a triangular face, prominent forehead, and body asymmetry. Maternal isodisomy of chromosome 7 is the only mechanism that comprehensively explains both the homozygous recessive condition (CF) and the imprinting disorder (Silver-Russell syndrome).

Step-by-Step Solution

1
Analyze the pulmonary and gastrointestinal symptoms along with the genetic test.
The patient has cystic fibrosis (CF) and is homozygous for the CFTR ΔF508\Delta F508 mutation.
Elevated sweat chloride and homozygous mutation confirm the CF diagnosis.
2
Evaluate the inheritance pattern given the parental genotypes.
The child inherited two copies of the mutant allele, but only the mother is a carrier (paternity is confirmed).
This discrepancy suggests either uniparental disomy, a de novo mutation, or a deletion on the paternal allele.
3
Analyze the additional dysmorphic physical exam findings.
The prominent forehead, triangular face, and limb hypoplasia (asymmetry) are classic signs of Silver-Russell syndrome.
These findings are not explained by cystic fibrosis alone.
4
Synthesize the findings to identify a single unifying genetic mechanism.
Maternal uniparental disomy of chromosome 7 causes Silver-Russell syndrome. If it occurs via isodisomy (duplication of the single mutant maternal chromosome), it also results in homozygosity for the CFTR mutation (located on chromosome 7).
This is the only mechanism that perfectly explains both the CF genotyping anomaly and the specific syndromic features.

Key Concept

Uniparental Isodisomy Unmasking Recessive Traits and Imprinting Disorders
Estimated Time:2m 0s
Question 292Question →

Match each clinical presentation to the underlying cellular adaptation mechanism it best represents.

Click a left item, then click its matching right item

Items

Echocardiography of a man with poorly controlled essential hypertension reveals a thickened left ventricular wall.
Biopsy of the distal esophagus in a patient with chronic reflux demonstrates replacement of native squamous epithelium with intestinal-type columnar epithelium.
Histologic evaluation of the prostate in a man with urinary hesitancy shows an increased number of normal-appearing glandular structures and fibromuscular stroma.
Examination of a woman six weeks after a radius fracture reveals significantly reduced girth of the affected forearm immediately following cast removal.

Matches

Show answer & explanation

Answer

The left ventricular thickening matches Hypertrophy. The esophageal epithelial change matches Metaplasia. The increased prostatic glandular structures match Hyperplasia. The reduced forearm girth matches Atrophy.
Each clinical vignette highlights a classic, fundamental mechanism by which cells adapt to environmental stressors, altered demand, or hormonal signals. Hypertrophy involves cell enlargement, metaplasia involves cell type switching, hyperplasia involves cell proliferation, and atrophy involves cell shrinkage.

Step-by-Step Solution

1
Analyze the cardiac presentation.
The myocardial cells have enlarged in response to increased afterload from hypertension.
Cardiac myocytes cannot undergo significant division; they adapt to mechanical stress solely by increasing in size (hypertrophy).
2
Analyze the esophageal presentation.
One mature epithelial type has been replaced by another type better suited to handle the acidic environment.
This reprogramming of stem cells to substitute the native tissue type with a more resilient one is the hallmark of metaplasia.
3
Analyze the prostatic presentation.
There is an absolute increase in the count of epithelial and stromal cells.
Hormonal stimulation (e.g., via dihydrotestosterone) triggers cellular proliferation, leading to hyperplasia.
4
Analyze the musculoskeletal presentation.
The skeletal muscle mass has decreased significantly due to lack of use.
Immobilization reduces the functional demand on the muscle, causing cells to degrade their own structural proteins and shrink, which is atrophy.

Key Concept

Cellular Adaptation
Question 293Question →

A 52-year-old male presents to the transplant nephrology clinic for evaluation of a low-grade fever and a significant decrease in his daily urine output. He received a living-donor kidney transplant one month ago. His vital signs are stable, but physical examination reveals mild tenderness over the allograft site in the right lower quadrant. Recent laboratory tests show an acute elevation in his serum creatinine from a baseline of 1.3 mg/dL to 2.9 mg/dL. Arrange the following clinical steps in the optimal sequence to diagnose and manage his suspected acute cellular rejection.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first perform a Doppler ultrasound, followed by a renal allograft biopsy, then initiate high-dose intravenous methylprednisolone, and finally administer anti-thymocyte globulin if the rejection is steroid-resistant.
The standard sequence for evaluating and managing acute renal allograft dysfunction begins with non-invasive imaging. A Doppler ultrasound rules out structural, vascular, or obstructive complications. Once these are ruled out, a percutaneous biopsy is performed to confirm the diagnosis of acute cellular rejection and rule out other pathologies. The first-line medical intervention is high-dose intravenous corticosteroids. If the rejection is severe or does not respond to corticosteroids (steroid-resistant), second-line therapy with lymphocyte-depleting antibodies is indicated.

Step-by-Step Solution

1
Evaluate the initial approach to acute renal allograft dysfunction.
Doppler ultrasound must be performed first.
It rapidly and noninvasively rules out reversible mechanical or surgical causes like obstruction, urine leak, or thrombosis before invasive procedures are considered.
2
Determine the next diagnostic requirement.
A percutaneous renal allograft biopsy is needed.
It provides the definitive histologic diagnosis required to direct specific immunosuppressive therapy and exclude polyomavirus nephropathy or calcineurin inhibitor toxicity.
3
Order the pharmacologic interventions.
High-dose steroids followed by anti-thymocyte globulin if needed.
Steroids are the standard first-line therapy, whereas potent lymphocyte-depleting agents are reserved for refractory or severe cases due to their side effect profile.

Key Concept

Management of acute renal allograft rejection
Question 294Question →

A 28-year-old woman is brought to the emergency department by ambulance due to the sudden onset of difficulty breathing, lip swelling, and a diffuse, intensely pruritic rash. The symptoms began approximately 15 minutes after she received her first dose of intravenous ceftriaxone for uncomplicated pyelonephritis at an urgent care clinic. Her temperature is 37.1°C (98.8°F), blood pressure is 78/45 mmHg, heart rate is 128/min, and respiratory rate is 26/min. Physical examination reveals stridor, diffuse expiratory wheezing, and bilateral angioedema of the face and lips. Which of the following mechanisms of action corresponds to the pharmacotherapy that must be administered immediately to stabilize this patient?

Show answer & explanation

Answer: Activation of alpha-1, beta-1, and beta-2 adrenergic receptors

Answer

Activation of alpha-1, beta-1, and beta-2 adrenergic receptors represents the mechanism of epinephrine, which is the immediate, life-saving treatment required for anaphylaxis.
The patient is experiencing acute anaphylaxis, a severe, systemic Type I (IgE-mediated) hypersensitivity reaction. The absolute priority in management is immediate stabilization of the airway and cardiovascular system. Epinephrine is the required first-line therapy. Its alpha-1 adrenergic agonism causes vasoconstriction, which increases blood pressure and reduces mucosal edema (relieving upper airway obstruction). Its beta-2 adrenergic agonism induces bronchodilation and suppresses further mast cell degranulation. Its beta-1 agonism provides necessary inotropic support.

Step-by-Step Solution

1
Identify the clinical syndrome based on the patient's presentation.
The patient has acute respiratory compromise (stridor, wheezing), profound hypotension, and mucocutaneous signs (urticaria, angioedema) shortly after antibiotic administration. This is diagnostic for acute anaphylaxis (Type I hypersensitivity).
Rapid recognition of systemic anaphylaxis is crucial because delays in appropriate treatment significantly increase mortality.
2
Determine the most appropriate immediate pharmacotherapy and identify its mechanism of action.
Intramuscular epinephrine is the required first-line treatment. It acts as an agonist at alpha-1, beta-1, and beta-2 adrenergic receptors.
Alpha-1 agonism causes vasoconstriction to increase blood pressure and decrease upper airway mucosal edema. Beta-2 agonism causes bronchodilation and decreases further mast cell mediator release.

Key Concept

The immediate management of acute Type I hypersensitivity (anaphylaxis) requires intramuscular epinephrine, which acts via alpha and beta adrenergic agonism to reverse systemic vasodilation, vascular permeability, and bronchospasm.
Estimated Time:1m 0s
Question 295Question →

A 3-year-old boy is evaluated in the pediatric genetics clinic due to excessive food-seeking behavior and rapid weight gain. His parents report that he had profound muscle hypotonia and required nasogastric tube feeding during his first month of life. Physical examination demonstrates central adiposity, small hands and feet, and undescended testes. Initial diagnostic testing with fluorescence in situ hybridization (FISH) for a microdeletion on chromosome 15q11-q13 is negative. Subsequent molecular testing with DNA methylation analysis reveals the presence of only maternally methylated alleles at the 15q11-q13 locus. Which of the following molecular mechanisms best explains these diagnostic findings?

Show answer & explanation

Answer: Inheritance of two homologous chromosomes from the maternal lineage and none from the paternal lineage

Answer

Inheritance of two homologous chromosomes from the maternal lineage and none from the paternal lineage
The correct answer is the inheritance of two homologous chromosomes from the maternal lineage and none from the paternal lineage. This patient's presentation of neonatal hypotonia followed by childhood hyperphagia, central obesity, and cryptorchidism is classic for Prader-Willi syndrome (PWS). PWS is caused by the loss of expression of paternally inherited genes on chromosome 15q11-q13. While a paternal microdeletion is the most common cause (~70% of cases), this was ruled out by the negative FISH test. The subsequent DNA methylation analysis showing exclusively maternally methylated alleles confirms that no paternal DNA is present at this locus. This combination of findings indicates maternal uniparental disomy (UPD), which occurs in ~25% of PWS cases. Because the maternal genes at this specific locus are normally silenced by epigenetic methylation (imprinting), inheriting two maternal copies results in a complete lack of active gene expression, leading to the clinical phenotype.

Step-by-Step Solution

1
Identify the underlying clinical syndrome based on the patient's presentation.
Prader-Willi syndrome (PWS).
The biphasic history of severe neonatal hypotonia and feeding difficulties followed by early childhood hyperphagia, obesity, and cryptorchidism is highly characteristic of PWS.
2
Interpret the sequential genetic testing results.
FISH is negative for a deletion, but DNA methylation analysis shows exclusively maternal patterns.
A negative FISH rules out a paternal microdeletion (the most common cause of PWS). The methylation analysis confirms that paternal alleles are entirely absent or inactive at this locus.
3
Determine the molecular mechanism that unifies the clinical diagnosis and laboratory findings.
Maternal uniparental disomy.
When a microdeletion is absent but only maternal alleles are detected, the patient has inherited two copies of chromosome 15 from the mother and zero from the father. Because maternal genes at 15q11-q13 are normally silenced (imprinted), the patient has no active copies.

Key Concept

Maternal uniparental disomy as a molecular etiology of Prader-Willi syndrome when a microdeletion is excluded.
Question 296Question →

A 4-month-old male infant is evaluated in the pediatric neurology clinic for severe generalized hypotonia, a weak cry, and absent deep tendon reflexes. Physical examination reveals prominent tongue fasciculations and paradoxical breathing. Genetic testing confirms a homozygous deletion of the survival motor neuron 1 (SMN1) gene. The medical team recommends initiating therapy with an intrathecal antisense oligonucleotide (ASO) designed to modulate the expression of the paralogous SMN2 gene. Arrange the following molecular and cellular events in the exact chronological order by which this targeted genetic therapy exerts its clinical effect, from initial molecular binding to ultimate cellular rescue.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with the targeted binding of the ASO to the SMN2 pre-mRNA, followed by the steric displacement of splicing repressors, successful inclusion of exon 7 by the spliceosome, translation of a stable full-length SMN protein, and ultimately the restoration of cellular snRNP biogenesis.
The precise molecular mechanism of nusinersen (an ASO for Spinal Muscular Atrophy) requires chronological understanding of molecular genetics. First, the ASO binds to the intronic splicing silencer N1 (ISS-N1) in the SMN2 pre-mRNA. Second, this binding sterically blocks the attachment of the splicing repressor hnRNP A1. Third, in the absence of the repressor, the spliceosome successfully recognizes the splice sites and includes exon 7. Fourth, this mature mRNA is translated into a full-length, stable SMN protein. Finally, the restored SMN protein complex resumes its critical cellular function in assembling small nuclear ribonucleoproteins (snRNPs), thereby preventing motor neuron apoptosis.

Step-by-Step Solution

1
Identify the genetic target of the therapeutic intervention.
The therapy is an antisense oligonucleotide targeting the SMN2 gene's pre-mRNA.
Understanding the drug class determines that its action occurs post-transcriptionally at the RNA level.
2
Determine the exact binding site and immediate molecular consequence.
The ASO binds to the ISS-N1 region in intron 7, which sterically hinders the binding of the splicing repressor hnRNP A1.
This specific structural interference is the primary mechanism of action for altering the splicing cascade.
3
Trace the downstream effect of repressor displacement on the splicing machinery.
The displacement of hnRNP A1 allows the spliceosome to recognize and include exon 7 in the mature mRNA transcript.
Exon 7 inclusion corrects the inherent splicing defect characteristic of the paralogous SMN2 gene.
4
Follow the mature mRNA to its functional protein product and cellular outcome.
The full-length mRNA is translated into a stable SMN protein, which then fulfills its vital role in snRNP biogenesis, ensuring motor neuron survival.
This links the initial molecular correction to the ultimate cellular and phenotypic rescue.

Key Concept

The pharmacogenomic mechanism of antisense oligonucleotide therapy in Spinal Muscular Atrophy involves modulating pre-mRNA splicing of the SMN2 gene to restore full-length SMN protein production.
Question 297Question →

During a routine health maintenance visit, a 42-year-old male accountant reports a gradual but significant decline in his exercise tolerance over the past two years. Previously an avid runner, he now experiences dyspnea after walking up a single flight of stairs. He is a lifelong non-smoker. His family history is notable for a father who died from cryptogenic liver cirrhosis at age 52. On physical examination, the patient has an increased anteroposterior chest diameter and globally diminished breath sounds. Spirometry reveals a forced expiratory volume in one second to forced vital capacity ratio (FEV1/FVC\text{FEV}_1/\text{FVC}) of 62%62\%, and carbon monoxide diffusing capacity (DLCO) is reduced to 45%45\% of the predicted value. Serum laboratory analysis demonstrates an aspartate aminotransferase level of 8585 U/L (reference range: 8−408-40 U/L) and an alanine aminotransferase level of 9292 U/L (reference range: 7−567-56 U/L). A chest radiograph displays significant hyperlucency at the lung bases. Which of the following best describes the molecular mechanism responsible for this patient's hepatic findings?

Show answer & explanation

Answer: Accumulation of a polymerized, misfolded glycoprotein within the rough endoplasmic reticulum

Answer

The correct answer identifies the accumulation of a polymerized, misfolded glycoprotein within the rough endoplasmic reticulum.
The correct answer identifies the distinct hepatic pathogenesis of alpha-1 antitrypsin (AAT) deficiency. The patient's clinical presentation of early-onset, lower-lobe predominant panacinar emphysema in a non-smoker, combined with unexplained liver disease, is classic for the PiZZ genotype of AAT deficiency. The PiZZ missense mutation causes the AAT glycoprotein to misfold. Because it is improperly folded, it cannot be secreted from the hepatocyte into the bloodstream. Instead, the mutant AAT molecules polymerize and accumulate within the rough endoplasmic reticulum (ER). This accumulation causes severe ER stress and hepatocellular apoptosis, eventually leading to liver cirrhosis.

Step-by-Step Solution

1
Synthesize the clinical and diagnostic findings.
The patient presents with early-onset, lower-lobe predominant panacinar emphysema (obstructive pattern, low DLCO, hyperlucency) and evidence of liver disease (elevated transaminases, family history of cirrhosis) in a non-smoker. This constellation is highly specific for alpha-1 antitrypsin (AAT) deficiency.
Accurately identifying the overarching syndrome is necessary to evaluate its underlying pathophysiology.
2
Differentiate the molecular mechanisms responsible for the pulmonary versus hepatic manifestations of the disease.
While the lung disease is caused by a loss-of-function (absence of AAT allows uninhibited neutrophil elastase to destroy alveolar walls), the liver disease is caused by a toxic gain-of-function. The PiZZ mutation causes the AAT protein to misfold and polymerize, trapping it in the rough endoplasmic reticulum of hepatocytes.
The question specifically asks for the mechanism of the hepatic findings, requiring the distinction between the two parallel disease processes.

Key Concept

Alpha-1 antitrypsin deficiency causes liver disease via a toxic gain-of-function mechanism, where misfolded AAT polymers accumulate in the rough endoplasmic reticulum of hepatocytes, causing ER stress and eventual cirrhosis.
Question 298Question →

A 32-year-old man comes to the clinic due to a painful, swollen boil on his left thigh. Physical examination shows a 3-cm erythematous, fluctuant skin abscess. He undergoes incision and drainage, and a sample is sent for culture. The culture grows Staphylococcus aureus that is resistant to oxacillin and cefazolin. Which of the following is the primary molecular mechanism responsible for this organism's antibiotic resistance?

Show answer & explanation

Answer: Production of an altered penicillin-binding protein

Answer

Production of an altered penicillin-binding protein
The correct answer identifies the production of an altered penicillin-binding protein. The patient's culture grew Staphylococcus aureus resistant to oxacillin, confirming an infection with methicillin-resistant Staphylococcus aureus (MRSA). MRSA resistance is primarily mediated by the acquisition of the staphylococcal cassette chromosome mec (SCCmec) containing the mecA gene. This gene encodes for PBP2a, a novel penicillin-binding protein with a significantly reduced binding affinity for all beta-lactam antibiotics, enabling the organism to synthesize peptidoglycan even in the presence of these drugs.

Step-by-Step Solution

1
Analyze the culture results provided in the vignette.
The patient has a skin abscess caused by Staphylococcus aureus that is resistant to oxacillin.
Identifying the specific organism and its resistance profile is necessary to determine the underlying molecular mechanism.
2
Correlate the resistance profile with the clinical entity.
Oxacillin-resistant S. aureus is clinically classified as methicillin-resistant S. aureus (MRSA).
Oxacillin and methicillin are structurally similar, and oxacillin resistance serves as the laboratory marker for MRSA.
3
Recall the molecular mechanism of resistance for MRSA.
MRSA strains acquire the mecA gene, which encodes for a variant penicillin-binding protein (PBP2a).
PBP2a has a very low affinity for beta-lactam antibiotics, allowing the bacteria to continue synthesizing its cell wall even in the presence of the drug.

Key Concept

Methicillin-resistant Staphylococcus aureus (MRSA) resistance is mediated by the mecA gene, which encodes an altered penicillin-binding protein (PBP2a) with reduced affinity for beta-lactam antibiotics.
Question 299Question →

Parents bring their 5-year-old son to the physician for evaluation of delayed motor milestones and a waddling gait. When rising from the floor, he places his hands on his thighs and pushes upwards to stand. Physical examination demonstrates prominent proximal muscle weakness and bilaterally enlarged, firm calf muscles. The physician strongly suspects an underlying X-linked recessive neuromuscular disorder. Arrange the following diagnostic interventions in the most appropriate sequential order to definitively establish the diagnosis according to current guidelines.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct diagnostic sequence begins with initial biochemical screening (serum CK), followed by targeted structural genetic testing for the most common defects (MLPA for large deletions/duplications). If negative, high-resolution genetic testing (gene sequencing) is performed. Finally, if all genetic testing is inconclusive, invasive tissue evaluation (muscle biopsy) is used.
The algorithm for diagnosing Duchenne muscular dystrophy requires a progression from the least invasive and most sensitive screening (CK level) to the most common genetic etiology (deletions/duplications via MLPA). If structural defects are absent, sequencing is performed to find point mutations. Muscle biopsy is the final, invasive alternative if genetics are unrevealing.

Step-by-Step Solution

1
Assess for biochemical evidence of generalized muscle breakdown.
Obtain a serum creatine kinase (CK) level.
It is a highly sensitive, rapid, and non-invasive initial screening test that will show massive elevations in Duchenne muscular dystrophy.
2
Perform first-line molecular diagnostic testing.
Order MLPA (or chromosomal microarray) to detect large structural variations.
Large deletions and duplications in the DMD gene account for the vast majority (roughly 70%) of cases and are easily identifiable with this technique.
3
Perform second-line molecular diagnostic testing if initial genetics are negative.
Order next-generation sequencing of the DMD gene.
Sequencing detects point mutations and small insertions/deletions that MLPA cannot identify, completing the genetic evaluation.
4
Proceed to invasive tissue sampling only if molecular tests fail.
Perform a muscle biopsy with immunohistochemistry.
Biopsy is definitive for absent dystrophin protein but is invasive; it is now reserved strictly for cases where genetic sequencing is non-diagnostic despite high clinical suspicion.

Key Concept

The stepwise diagnostic algorithm for Duchenne muscular dystrophy prioritizes non-invasive screening and targeted molecular genetic testing before invasive tissue biopsy.
Question 300Question →

A 32-year-old man visits the primary care clinic to establish care and discuss management of recently diagnosed essential hypertension. He reports a lifelong history of episodic, unprovoked swelling of his lips, tongue, and extremities. These episodes typically last 48 to 72 hours and are not associated with urticaria or pruritus. His father and paternal grandfather experienced similar symptoms throughout their lives. Recent laboratory testing confirms a deficiency of C1 esterase inhibitor. The patient's blood pressure today is 152/94 mm Hg. The physician decides to initiate antihypertensive therapy. Which of the following medications is strictly contraindicated in this patient?

Show answer & explanation

Answer: Lisinopril

Answer

Lisinopril
The correct medication to avoid is an angiotensin-converting enzyme (ACE) inhibitor, such as lisinopril. ACE is also known as kininase II, the enzyme largely responsible for degrading bradykinin. This patient has hereditary angioedema due to C1 esterase inhibitor deficiency, a condition characterized by excessive bradykinin production. Administering an ACE inhibitor to this patient prevents the breakdown of bradykinin, leading to massive accumulation that can rapidly precipitate severe, life-threatening airway edema.

Step-by-Step Solution

1
Identify the patient's underlying condition.
The patient has hereditary angioedema (HAE), indicated by recurrent non-pruritic swelling, family history, and confirmed C1 esterase inhibitor deficiency.
Establishing the correct diagnosis is required to understand which pharmacologic pathways are disrupted.
2
Determine the pathophysiologic mechanism of the disease.
C1 esterase inhibitor deficiency leads to unchecked kallikrein activity and subsequent overproduction of bradykinin, which causes the severe tissue swelling.
Understanding the bradykinin excess explains the patient's baseline risk for angioedema.
3
Evaluate the medication options for contraindications related to bradykinin.
Lisinopril (an ACE inhibitor) blocks the degradation of bradykinin. It is strictly contraindicated as it can precipitate life-threatening swelling.
ACE inhibitors are a well-known trigger for angioedema and must be avoided in patients who already have a genetic predisposition to elevated bradykinin.

Key Concept

Patients with hereditary angioedema (C1 esterase inhibitor deficiency) have elevated bradykinin levels. Angiotensin-converting enzyme (ACE) inhibitors prevent the degradation of bradykinin and are strictly contraindicated as they can precipitate severe, potentially fatal angioedema.
PreviousPage 15 / 22Next
Foundational Science and Mechanisms of Disease Practice Questions — USMLE Step 3 — Page 15 | Examkin